|Mr. Nicholas Keane Vita||Co-Founder, CEO & Director||846.88k||N/A||1973|
|Mr. David J. Hart||Chief Operating Officer||510.54k||N/A||1977|
|Mr. Derek Watson||Chief Financial Officer||N/A||N/A||1971|
|Dr. Rosemary Mazanet M.D., Ph.D.||Chief Scientific Officer||N/A||N/A||1956|
|Mr. Bryan Lamont Olson||Chief People & Admin. Officer||N/A||N/A||1974|
|Ms. Lee Ann Evans||VP of Investor Relations||N/A||N/A||N/A|
|Kate Driscoll||VP of Compliance||N/A||N/A||N/A|
|Mr. David Sirolly||Chief Legal Officer & Gen. Counsel||N/A||N/A||1975|
|Mr. Bryant Ison||Chief Marketing Officer||N/A||N/A||N/A|
|Mr. Guy Jacques Hussussian||Chief Data Officer||N/A||N/A||1967|
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Columbia Care Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.